Atlas Trials

Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients

Clinical trial NCT02864498 · COMPLETED

Trial details

NCT number
NCT02864498
Sponsor
DS Biopharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2017-01-01
Primary completion
2018-06-01
Enrollment
321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.